Leadership & Pay · · GlobeNewswire
Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer
RANIRani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. announced the appointment of Nicholas Maestas as its new Chief Financial Officer, effective immediately. Mr. Maestas joins from Tempest Therapeutics, where he served as CFO and head of corporate strategy. He succeeds Svai Sanford, who left the company in May 2026 to pursue other opportunities. Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies for orally administered biologics and drugs.